Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
18 March, 2018 07:18 IST
Lupin launches generic Kapvay tablets in US
Source: IRIS | 08 Feb, 2018, 04.03PM
Comments  |  Post Comment

Pharma major Lupin announced the launch of its Clonidine Hydrochloride extended-release tablets, 0.1mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Clonidine Hydrochloride ER tablets is the generic equivalent of Concordia International Corp's Kapvay tablets. It is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications.

Kapvay tablets had annual sales of approximately USD 66 million in the US (IQVIA MAT December 2017). 

Shares of the company gained Rs 6.5, or 0.8%, to settle at Rs 814.45. The total volume of shares traded was 154,072 at the BSE (Thursday).

Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Related Articles
Yes Bank provides financial assistance to Mahindra Renewables' mega solar project - 16-Mar-2018 12:58
L&T Construction & DFCCIL sign contract worth Rs 28.64 bn - 16-Mar-2018 12:42
Muthoot Finance ties up with Global IME Bank - 16-Mar-2018 10:17
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer